Syngeneic Syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting-Reference-Cited by-同舟云学术

Syngeneic Syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting

Published:2016-02-18 Issue:5 Volume:5 Page:e1136046
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Siurala Mikko,Vähä-Koskela Markus,Havunen Riikka,Tähtinen Siri,Bramante Simona,Parviainen Suvi,Mathis J. Michael,Kanerva Anna,Hemminki Akseli

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1136046

Reference51 articles.

1. A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes

2. Exploiting the curative potential of adoptive T-cell therapy for cancer

3. IL-2: The First Effective Immunotherapy for Human Cancer

4. Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas

5. Trial Watch:

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy;Frontiers in Immunology;2023-02-27

2. Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses;Expert Opinion on Biological Therapy;2022-11-02

3. Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers;Diseases;2022-08-08

4. Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers;Cells;2021-04-22

5. Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors;Molecular Therapy - Oncolytics;2020-06